Molecular Cancer Research

Published by: American Association for Cancer Research  

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. De Stanchina
    De Stanchina
  3. Rosen
    Rosen
  4. Aghajanian
    Aghajanian
  5. Antonescu
    Antonescu
  6. Balestrini
    Balestrini
  7. Besmer
    Besmer
  8. Caird
    Caird
  9. Carlo
    Carlo
  10. Carver
    Carver

Groups

  1. Department of Medicine (10)
  2. Hematologic Malignancies, Division of (10)
  3. GSK Faculty (7)
  4. Sloan Kettering Institute Postdocs (6)
  5. Human Oncology and Pathogenesis Program (5)
  6. Sloan Kettering Institute Faculty (5)
  7. Solid Tumor Oncology Division (5)
  8. Tow Center for Developmental Oncology (TCDO) (5)
  9. Center for Hematologic Malignancies (4)
  10. Executive Committee, Center for Hematologic Malignancies (4)
Search Within
  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (10)
  2. Hematologic Malignancies, Division of (10)
  3. GSK Faculty (7)
  4. Sloan Kettering Institute Postdocs (6)
  5. Human Oncology and Pathogenesis Program (5)
  6. Sloan Kettering Institute Faculty (5)

More Groups

People
  1. Bayard Clarkson (2)
  2. Elisa De Stanchina (2)
  3. Neal Rosen (2)
  4. Omar Abdel-Wahab (2)
  5. Abraham Hakimi (1)
  6. Adam Schoenfeld (1)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (2)
  5. 2016 (1)
  6. 2014 (1)

More Years

Publishers
  1. American Association for Cancer Research (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overlaid transcriptional and proteome analyses identify mitotic kinesins as important targets of arylsulfonamide-mediated RBM39 degradation
    Journal Article

    Coomar, S.; Mota, P.; Penson, A.; Schwaller, J.; Abdel-Wahab, O.; Gillingham, D.
    Molecular Cancer Research (2023)

    Fulltext@MSK | Save
  • MYC promotes tyrosine kinase inhibitor resistance in ROS1-fusion-positive lung cancer
    Journal Article

    Iyer, S. R.; Odintsov, I.; Schoenfeld, A. J.; Siau, E.; Mattar, M. S.; de Stanchina, E.; Khodos, I.; Drilon, A.; Riely, G. J.; Ladanyi, M.; more...
    Molecular Cancer Research (2022)

    Fulltext@MSK | Save
  • High response rate and durability driven by HLA genetic diversity in patients with kidney cancer treated with lenvatinib and pembrolizumab
    Journal Article

    Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Valero, C.; Vuong, L.; Lee, M.; Weiss, K.; Hoen, D.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Activating alterations of p110 subunits determine PI3K isoform selectivity in prostate cancer
    Meeting Abstract

    Zhang, Z.; Mao, N.; Lee, Y. S.; Li, D.; Rosen, N.; Sawyers, C.; Carver, B.
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer
    Meeting Abstract

    Rubinstein, M. M.; Hyman, D.; Caird, I.; O'Cearbhaill, R.; Grisham, R.; Tew, W.; Hensley, M.; Sabbatini, P.; Aghajanian, C.; Iasonos, A.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Defining ATM-independent functions of the mre11 complex with a novel mouse model
    Journal Article

    Balestrini, A.; Nicolas, L.; Yang-Lott, K.; Guryanova, O. A.; Levine, R. L.; Bassing, C. H.; Chaudhuri, J.; Petrini, J. H. J.
    Molecular Cancer Research (2016)

    Fulltext@MSK | Save
  • Oncogenic RAF mutants that signal as functional dimers are resistant to current RAF inhibitors but sensitive to a novel inhibitor of RAF dimer kinase activity
    Meeting Abstract

    Yao, Z.; Torres, N. M.; Wei, M.; Hanrahan, A.; Abdel-Wahab, O.; Solit, D.; Luo, L.; Poulikakos, P.; Rosen, N.
    Molecular Cancer Research (2014)

    Fulltext@MSK | Save
  • Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib
    Journal Article

    Rossi, F.; Yozgat, Y.; de Stanchina, E.; Veach, D.; Clarkson, B.; Manova, K.; Giancotti, F. G.; Antonescu, C. R.; Besmer, P.
    Molecular Cancer Research (2010)

    Fulltext@MSK | Save
  • TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression
    Journal Article

    Asakura, K.; Uchida, H.; Miyachi, H.; Kobayashi, H.; Miyakawa, Y.; Nimer, S. D.; Takahashi, H.; Ikeda, Y.; Kizaki, M.
    Molecular Cancer Research (2004)

    Fulltext@MSK | Save
  • Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between kit ligand and cytokines in primary primitive progenitor cells
    Journal Article

    Strife, A.; Wisniewski, D.; Liu, C.; Lambek, C. L.; Darzynkiewicz, Z.; Silver, R. T.; Clarkson, B.
    Molecular Cancer Research (2003)

    Fulltext@MSK | Save

    • Molecular Cancer Research – authorized name for:

    Name ISSN / ISBN Publisher
    Molecular Cancer Research 1541-7786 American Association for Cancer Research
    Molecular Cancer Research 1541-7786 American Association for Cancer Research
    Molecular Cancer Research 15417786 American Association for Cancer Research
    Molecular Cancer Research 15417786 American Association for Cancer Research
    Molecular Cancer Research 1541-7786 Unknown
    Molecular Cancer Research 15417786 Unknown
    Molecular Cancer Research 15417786 American Association for Cancer Research
    Molecular Cancer Research 15417786 The Authors the American Association for Cancer Research
    Molecular Cancer Research 15417786 American Association for Cancer Research
    Molecular Cancer Research 1541-7786 American Association for Cancer Research
    Molecular Cancer Research 1541-7786 American Association for Cancer Research
    Molecular cancer research : MCR 15573125 American Association for Cancer Research